Verona Pharma news

7 October 2025
Merck Acquires Verona Pharma
Merck enhances its cardio-pulmonary portfolio with Ohtuvayre, a novel COPD treatment, following the $10 billion acquisition of Verona Pharma.

What's Verona Pharma up to in Europe?

Find out with chemXplore Analytics